Accumulation of MxB/Mx2-resistant HIV-1 Capsid Variants During Expansion of the HIV-1 Epidemic in Human Populations

EBioMedicine. 2016 Jun:8:230-236. doi: 10.1016/j.ebiom.2016.04.020. Epub 2016 Apr 17.

Abstract

Recent studies have identified human myxovirus resistance protein 2 (MxB or Mx2) as an interferon induced inhibitor of HIV-1 replication. However, whether HIV-1 can overcome MxB restriction without compromise of viral fitness has been undefined. Here, we have discovered that naturally occurring capsid (CA) variants can render HIV-1 resistant to the activity of MxB without losing viral infectivity or the ability to escape from interferon induction. Moreover, these MxB resistant HIV-1 variants do not lose MxB recognition. Surprisingly, MxB resistant CA variants are most commonly found in the Clade C HIV-1 that is the most rapidly expanding Clade throughout the world. Accumulation of MxB resistant mutations is also observed during HIV-1 spreading in human populations. These findings support a potential role for MxB as a selective force during HIV-1 transmission and evolution.

Keywords: Capsid variants; HIV-1; MxB; Positive selection.

MeSH terms

  • Anti-HIV Agents / pharmacology*
  • Capsid Proteins / chemistry
  • Capsid Proteins / genetics*
  • China / epidemiology
  • Drug Resistance, Viral*
  • Genetic Fitness
  • Genetic Variation
  • Geography
  • HIV Infections / epidemiology*
  • HIV Infections / virology*
  • HIV-1 / drug effects*
  • HIV-1 / genetics*
  • Humans
  • Models, Molecular
  • Myxovirus Resistance Proteins / pharmacology*
  • Population Surveillance
  • Protein Conformation
  • Virus Replication

Substances

  • Anti-HIV Agents
  • Capsid Proteins
  • MX2 protein, human
  • Myxovirus Resistance Proteins